In particular, a number of studies have suggested that PKC and extracellular signal-regulated protein kinase 1/2 (ERK 1/2) might be concordantly regulated in the process of cardiac hypertrophy, extending to CHF [59]. The gene discussed is PRRT2; the disease is cardiac hypertrophy.